Australia Markets close in 11 mins

Nanosonics and these ASX 200 shares doubled in value in 2019

James Mickleboro
ASX shares rise

The S&P/ASX 200 index was on form in 2019 and recorded a gain of over 20% excluding dividends.

Whilst this is incredibly positive, some shares on the index managed to thoroughly outperform it.

Three shares that more than doubled in value in 2019 are listed below. Here’s why they smashed the market last year:

Fortescue Metals Group Limited (ASX: FMG)

The Fortescue share price was on fire in 2019 and recorded a stunning 178% gain. Investors were fighting to get hold of the iron ore producer’s shares following a sharp rise in the price of the steel making ingredient. This was driven by a combination of solid demand from China and supply disruptions in Australia and Brazil. Also catching the eye of investors was the grade of its iron ore. Traditionally, Fortescue has been a producer of low grade ore, but was steadily increasing its grade in 2019. This has allowed Fortescue to benefit even more from the higher prices. Which has ultimately led to the company generating significant free cash flows, allowing it to pay down debt and reward shareholders with very generous dividends.

Nanosonics Ltd (ASX: NAN) 

The Nanosonics share price was on form again in 2019 and rocketed 123% higher. The catalyst for this strong gain was an impressive performance in FY 2019. During the 12 months Nanosonics posted record full year sales of $84.3 million and a record operating profit before tax of $16.8 million. This was a 39% and 120% increase, respectively, on the prior corresponding period. The good news is that further strong growth is expected in FY 2020. After which, the release of several new products in the near future are expected to bolster its growth from FY 2021 onwards.

Pro Medicus Limited (ASX: PME)

The Pro Medicus share price posted a sizeable 105% gain in 2019. Investors were buying the health imaging company’s shares thanks largely to its stellar profit growth in FY 2019. During the 12 months Pro Medicus posted a profit of $19.1 million, which was up 91.9% on the prior corresponding period. Also supporting Pro Medicus’ shares was its inclusion in the benchmark S&P/ASX 200 index at the June quarterly rebalance. This brought the company onto the radar of fund managers with strict investment mandates and index tracking ETFs.

The post Nanosonics and these ASX 200 shares doubled in value in 2019 appeared first on Motley Fool Australia.

Looking for the shares that could double in 2020? I think one of these five shares has the potential to do so.

NEW. Five Cheap and Good Stocks to Buy for now and beyond!….

Our Motley Fool experts have just released a fantastic report, detailing 5 dirt cheap shares that you can buy today.

One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

Another is a diversified conglomerate trading near a 52-week low all while offering a 2.6% fully franked yield...

Plus 3 more cheap bets that could position you to profit over the next 12 months!

See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.

CLICK HERE FOR YOUR FREE REPORT!

More reading

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited. The Motley Fool Australia has recommended Pro Medicus Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2020